Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model

Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size

Manisha P. Desai, Vinod Labhasetwar, Gordon L. Amidon et al. · Pharmaceutical Research · 1996 · 935 citations · Full text

Pharmacy, Pharmaceutics, Pharmacokinetics +16

Biologically erodable microspheres as potential oral drug delivery systems

Edith Mathiowitz, Jules S. Jacob, Yong S. Jong et al. · Nature · 1997 · 824 citations

Pharmacy, Bioengineering, Pharmaceutics +14

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.

Circulation · 1992 · 544 citations · Full text

Medicine, Cardiology, Pharmacology +17

A Comparison of Hirudin with Heparin in the Prevention of Restenosis after Coronary Angioplasty

Patrick W. Serruys, Jean‐Paul R. Herrman, Rüdiger Simon et al. · New England Journal of Medicine · 1995 · 393 citations · Full text

Medicine, Cardiology, Pharmacology +14

Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery

Cuxian Song, Vinod Labhasetwar, Hedwig S. Murphy et al. · Journal of Controlled Release · 1997 · 365 citations

Pharmacy, Biomedical Engineering, Pharmaceutics +14